Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin Proline Tablets and Visceral Fat in Type 2 Diabetes Mellitus
ChiCTR2400085789Phase 4Not yet recruiting
- Sponsor
- Maanshan Municipal Hospital Group
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of henagliflozin in type 2 diabetes mellitus (T2DM), Overweight and obesity (2 arms), sponsored by Maanshan Municipal Hospital Group. Primary endpoint: Visceral fat area. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)Overweightobesity
Beyond the preview
Go deeper on ChiCTR2400085789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085789.